Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
Coya Therapeutics Inc. (COYA)
Market is closed
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.19 | 1,800 | $12,934.44 | 8,800 | 2024-11-14 | Filing | |
| $7.36 | 5,000 | $36,797.00 | 10,000 | 2024-11-13 | Filing | |
| $7.37 | 2,710 | $19,972.70 | 2,710 | 2024-11-11 | Filing | |
| $7.34 | 5,000 | $36,689.00 | 5,000 | 2024-11-11 | Filing | |
| $3.62 | 1,000 | $3,620.00 | 17,479 | 2023-08-22 | Filing |
News See All
Billionaire David Einhorn's 5 Stock Picks with Huge Upside Potential
In this article, we will take a look at billionaire David Einhorn’s 5 stock picks with huge upside potential.
Hedge Fund and Insider Trading News: David Einhorn, Stan Druckenmiller, Ray Dalio, Paul Tudor Jones, George Soros, Modulo Capital, Altisource Portfolio Solutions S.A. (ASPS), Moderna, Inc. (MRNA), and More
David Einhorn, Founder and President of Greenlight Capital exited his stakes in Intel (INTC), Rivian Automotive (RIVN), and News Corp. (NWS) in Q4, according to the hedge fund’s 13-F filing.
Billionaire Hedge Funds
